Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 8/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | MGLL | Q99685 | 2/20 | 0.64 |
| ▸ | CA4 | P22748 | 1/20 | 0.61 |
| ▸ | CA6 | P23280 | 1/20 | 0.61 |
| ▸ | CA5A | P35218 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | LPL | P06858 | 2/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14330056 | 0.87 | ENPP2 (0.56) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL12619984 | 0.85 | MGLL (0.86) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL31139484 | 0.85 | MGLL (0.86) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL30712840 | 0.85 | MGLL (0.86) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL29940011 | 0.84 | MGLL (0.61) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL29547555 | 0.83 | ENPP2 (0.58) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL4933 | 0.83 | ENPP2 (0.58) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL8884 | 0.83 | ENPP2 (1.00) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL22913 | 0.81 | ENPP2 (1.00) | ENPP2KDM4EALDH1A1MGLLCA4 | |
| SCHEMBL12875497 | 0.81 | ENPP2 (0.56) | ENPP2KDM4EALDH1A1MGLLCA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534811-A | Polyurea material based on boron-linked crosslinking and preparation method thereof | 四川大学 | 2024-02-09 | — | — | CN | claimed |
| CN-117467108-A | High-impact polyurea material with boron-containing structure chain extension and preparation method thereof | 四川大学 | 2024-01-30 | — | — | CN | claimed |
| EP-4280882-A2 | MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS | JP LABORATORIES, INC. (US) | 2023-11-29 | — | — | EP | claimed |
| CN-116284797-A | Rubber material containing polyborosiloxane and preparation method thereof | 成都魔极科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116285373-A | Modified silicone rubber containing polyborosiloxane and preparation method thereof | 成都魔极科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-11634616-B1 | Methods of assembling apparel products having boronate adhesives | CREATEME TECHNOLOGIES INC. | 2023-04-25 | — | — | US | claimed |
| CN-115216013-A | Poly-linked borosilicate siloxane rubber material and preparation method thereof | 四川大学 | 2022-10-21 | — | — | CN | claimed |
| EP-3419987-A1 | AFFINITY LIGAND FOR THE PURIFICATION OF GLYCOSYLATED BIOMOLECULES | Hochschule für Technik und Wirtschaft (HTW) Berlin (DE) | 2019-01-02 | — | — | EP | claimed |
| WO-2017144099-A1 | AFFINITY LIGAND FOR THE PURIFICATION OF GLYCOSYLATED BIOMOLECULES | HOCHSCHULE FÜR TECHNIK UND WIRTSCHAFT (HTW) BERLIN (DE) | 2017-08-31 | — | — | WO | claimed |
| WO-2006069087-A2 | PREPARATION OF METAL CHALCOGENIDE NANOPARTICLES AND NANOCOMPOSITES THEREFROM | APS LABORATORY (US) | 2006-06-29 | — | — | WO | claimed |
| WO-2005035668-A2 | PREPARATION OF METAL NANOPARTICLES AND NANOCOMPOSITES THEREFROM | APS LABORATORY (US) | 2005-04-21 | — | — | WO | claimed |
| WO-2004063288-A1 | METAL OXIDE SOLS AS NANOSCALE ADDITIVES FOR POLYMERS | APS LABORATORY (US) | 2004-07-29 | — | — | WO | claimed |
| US-12637436-B2 | Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof | Sanford Burnham Prebys Medical Discovery Institute (US) | 2026-05-26 | — | — | US | disclosed |
| CN-121698494-B | Phosphorus-free composite scale inhibitor and preparation method thereof | 盛坤新材料(山东)有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260116893-A1 | ORGANIC COMPOUND | SEMICONDUCTOR ENERGY LAB (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4558580-B1 | FOAMED GEL SYSTEM FOR WATER SHUT OFF IN SUBTERRANEAN ZONES | SAUDI ARABIAN OIL CO (SA) | 2026-02-25 | — | — | EP | disclosed |
| WO-2002042281-A1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-05-30 | — | — | WO | disclosed |
| US-20020038004-A1 | 1,2-phenylenediboronic acid reagents and complexes | PROLINX, INC. | 2002-03-28 | — | — | US | disclosed |
| US-6124471-A | Phenyldiboronic acid reagents and complexes | PROLINX, INC. (US) | 2000-09-26 | — | — | US | disclosed |
| US-6075126-A | Phenyldiboronic acid reagents and complexes | PROLINX, INC. (US) | 2000-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116893-A1 | ORGANIC COMPOUND | CCNA1, AR, CCNT1 | ENPP2 2915/4885KDM4E 3734/4885ALDH1A1 318/4885 |
| US-20020038004-A1 | 1,2-phenylenediboronic acid reagents and complexes | BCR, MGST1, SULT1E1 | ENPP2 3879/4885KDM4E 2180/4885ALDH1A1 526/4885 |
| US-12637436-B2 | Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof | GRM3, GRM2, GRM1 | ENPP2 1668/4885KDM4E 1949/4885ALDH1A1 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.